Oppenheimer Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US6837971042
USD
67.87
-0.62 (-0.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Oppenheimer Holdings, Inc. stock-summary
stock-summary
Oppenheimer Holdings, Inc.
Capital Markets
Oppenheimer Holdings Inc. is a middle-market investment bank and service broker-dealer. The Company is engaged in a range of activities in the securities industry, including retail securities brokerage, institutional sales and trading, investment banking, research, market-making, trust services, and investment advisory and asset management services. Its segments are Private Client, which provides financial services in the United States; Asset Management, which offers investment advisory services to its retail and institutional clients; Capital Markets, includes investment banking, institutional equities sales, trading, and research, taxable fixed income sales, trading, and research, public finance and municipal trading; Commercial Mortgage Banking, engaged in the business of originating and servicing Federal Housing Administration insured multifamily and healthcare facility loans and securitizing these loans into Government National Mortgage Association mortgage-backed securities.
Company Coordinates stock-summary
Company Details
85 Broad St Fl 22 , NEW YORK NY : 10004-2434
stock-summary
Tel: 1 212 8254331
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 23 Schemes (17.84%)

Foreign Institutions

Held by 33 Foreign Institutions (2.46%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Albert Lowenthal
Chairman of the Board, Chief Executive Officer
Mr. Paul Friedman
Lead Independent Director
Mr. Robert Lowenthal
Director
Mr. Evan Behrens
Independent Director
Mr. Timothy Dwyer
Independent Director
Mr. William Ehrhardt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
373 Million
(Quarterly Results - Jun 2025)
Net Profit:
22 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 760 Million (Small Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.75%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

9.76%

stock-summary
Price to Book

0.85